GSK has agreed to acquire US clinical-stage oncology specialist Nuvalent for $10.6 billion, its largest deal in years, to accelerate entry into lung cancer and boost growth through the dolutegravir patent cliff.
Wacker has sold 2.1 million Siltronic shares for € 89.35 per Siltronic share. The sale corresponds to 7% of Siltronic's share capital and reduces Wacker's stake in Siltronic to around 24%.
Acquisition strengthens US peptide manufacturing capabilities and broadens global expertise in complex peptide APIs
Irish water treatment specialist CSG acquires UK distributor Resource Chemicals, pushing group revenue past €100 million and advancing its strategy to build a full-service platform across Ireland and the UK.
Alcami completes its acquisition of Tjoapack, creating a 1,400-strong CDMO with over one million square feet of operations across the US and the Netherlands, adding European packaging scale and QP release services.
The provisional insolvency administrator of Vynova Wilhelmshaven has signed a letter of intent with the US chemicals group Westlake regarding the acquisition of the production site for polyvinyl chloride and vinyl chloride monomer in Wilhelmshaven.
Shrieve Chemical Company has acquired Aberdeen-based FIS Chemicals, expanding Shrieve’s product portfolio and presence across key industrial end markets; deal terms were not disclosed.
Ineos Inovyn to sell its stake in Italy’s Inovyn Produzione Italia (Rosignano, Tavazzano sites) to Esseco Industrial. Deal expected in 2026, pending approvals; operations and supply unchanged during transition.
Asahi Kasei has completed its acquisition of Germany’s Aicuris, adding three antiviral assets, in a deal previously reported at about €780 million.
Acquisition includes industry-leading ADC platform, its clinically-validated tubutecan linker-payload technology, and next-generation platform to expand Gilead’s ADC capabilities.
Colonial Chemical Solutions has acquired Integrity Partners Group, adding Chemisphere and Chemsolv to expand its Southeast footprint, capabilities, and customer reach in chemical distribution.
Merck has launched its acquisition of Terns Pharmaceuticals, a deal valued at about $6.7 billion that would add to its hematology portfolio.
Prange Pharma has completed its acquisition of MSD Animal Health’s Aprilia site in Italy, which will now operate as Aprilia Animal Health, a new European CDMO platform for the animal health sector.
BASF Agricultural Solutions recently completed the acquisition of AgBiTech. This follows the agreement signed in January 2026 with private equity firm Paine Schwartz Partners and other shareholders.
Adragos Pharma has acquired Sanofi’s Maisons-Alfort sterile fill-finish site in France, expanding its European manufacturing network and prefilled syringe capabilities.
The acquisition marks Samsung Biologics’ geographical diversification, establishing its first US manufacturing presence and expanding regional client support.
Lonza signs agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds, for an enterprise value of $3 billion (CHF 2.3 billion).
Kearney's 2026 Chemicals Executive M&A Report forecasts strengthened global deal activity after 2025 gains, with executives anticipating more small-to-mid-size transactions.
Asahi Kasei will acquire all shares in the German biopharmaceutical company Aicuris Anti-infective Cures for approximately €780 million.
Alkermes has finalized its acquisition of Avadel Pharmaceuticals, bolstering its presence in the sleep medicine market.
Sanofi has completed its acquisition of Dynavax, adding its adult vaccines and pipeline candidates to strengthen Sanofi’s presence in adult immunization.
Umicore Precious Metals Chemistry (Umicore PMC) has acquired high-throughput screening (HTS) and specialty ligand technologies from Solvias, with services transitioning during 2026.
Henkel has agreed to acquire Dutch-based specialty coatings company Stahl for €2.1 billion to strengthen and expand its Adhesive Technologies business into adjacent high-performance coatings markets.
GSK announced a definitive agreement to acquire RAPT Therapeutics for $2.2 billion, gaining rights to ozureprubart, a next-generation treatment that could protect food allergy patients.
Agno Pharma acquired Actylis's Eugene, Oregon CDMO facility, formerly Cascade Chemistry, for small-molecule API development and manufacturing, thereby expanding its US footprint.
The acquisitions strengthens HSH Chemie’s sweetener and sugar alternatives
portfolio, adding established fructose expertise, long-standing customer
relationships, and international market access.
Arkema and Praana Group announced that they have entered into a proposed transaction under which Praana would acquire selected plastic additives businesses from Arkema.
Dystar has become a wholly owned subsidiary of Zhejiang Longsheng Group following the $688.9 million buyout of KIRI Industries’ 37.5% stake, marking the end of a long shareholder dispute.
Strong Supply Chains, Efficiency, Digitalization, and Talent Development are Crucial for Chemical Distributors
Akzo Nobel has completed the sale of Akzo Nobel India, including its liquid paints and coatings business, to the JSW Group for an enterprise value of about €1.4 billion.
CABB Group has signed a definitive agreement to sell its US-based subsidiary Jayhawk Fine Chemicals to Anupam Rasayan, marking Anupam’s entry into US manufacturing and supporting CABB’s strategic focus on pharma.
The two Japanese companies Asahi Kasei and Teijin are merging their trading divisions.
Harbour Group's Americo has acquired Fusion Chemical, a specialty metalworking fluids manufacturer based in Huntington, Indiana, expanding its product offerings and capacity for growth.
Halozyme has acquired Elektrofi to expand its drug delivery portfolio, with royalty revenues expected to start by 2030 as partnered products advance to clinical development.
Johnson & Johnson is acquiring clinical-stage biotech Halda Therapeutics for $3.05 billion to enhance its oncology pipeline.
